20210723-empowered-patient-podcast

July 26, 2021

Learn more about our intranasal approach on the Empowered Patient Podcast 

Karen Jacoda interviewed Leyden Labs' CEO, Koenraad Wiedhaup for the Empowered Patient Podcast. Karen highlights latest innovations in healthcare, pharma and biotech and changing dynamics between patients and physicians in her podcast. During this interview, Karen and Koenraad spoke about Leyden Labs' proactive approach toward viral threats. Instead of eliminating viruses one by one, we are developing broad protection - tackling entire virusfamilies, such as influenza or coronaviruses, at once. 

Leyden Labs is working on simple, easy-to-use nasal sprays that do not need a healthcare professional to administer the spray. Self-administration has multiple benefits: it provides people with the autonomy to decide for themselves when and where they want (additional) protection. Moreover, a rollout will be much easier than we experienced with e.g. the COVID-19 vaccines, especially in remote areas with limited healthcare professionals available. 

Listen to the full interview below.

LL-Blue

OUR NEW APPROACH  |  OUR TEAM  |  JOIN OUR MISSION   |  NEWS  |  CAREERS  

Contact

Media inquiries

Stay updated

Leyden Laboratories B.V.

Leiden Laboratory
J.H. Oortweg 21
2333 CH Leiden
The Netherlands


Leyden Laboratories Co.

Boston Laboratory
191 Dexter Avenue
Watertown
MA 02472
United States


Leyden Labs S.L.

Granada Office
Avda. del Conocimiento 41.A214
Centro de Empresas
Parque Tecnológico de la Salud
18016 Granada
Spain


© Leyden Labs, 2021  |  Privacy Policy  |  Design by Ape to Zebra

Back to top Arrow